AI & Automation

Drug discovery,
reimagined by AI.

Our AI-native platform compresses the drug discovery timeline from years to months — combining generative chemistry, robotic synthesis, and predictive biology.

100x

Faster hypothesis

10k+

Compounds/cycle

85%

Fewer trial failures

See Pipeline

Platform Capabilities

End-to-end automation of the discovery cycle.

Molecular Hypothesis Generation

ML models trained on bioactivity datasets generate novel compound hypotheses in hours, not months.

100xfaster hypothesis generation

Automated Synthesis & Screening

Robotic lab systems run parallel synthesis and high-throughput screening with zero human downtime.

10k+compounds screened per cycle

Predictive ADMET Profiling

AI predicts absorption, distribution, metabolism, excretion, and toxicity before any wet-lab work.

85%reduction in failed trials

Clinical Trial Optimization

NLP and predictive analytics streamline patient recruitment, protocol design, and endpoint selection.

3xfaster trial completion

Foundation Model

The Solenyx
Silicon
Architecture.

Our proprietary generative AI engine continuously trains on over 40 million bioactivity data points. It does not just screen existing compounds; it hallucinates structurally novel therapeutics optimized for synthesized viability.

View Model Weights

Fig. 2 — Neural Graph

Compute Cluster Active

Discovery Pipeline

From data to drug candidate.

Data Ingestion

Bioactivity databases, genomics, and literature are ingested and indexed by our foundation model.

Target Identification

Graph neural networks map protein-ligand interactions to identify novel therapeutic targets.

Lead Optimization

Generative chemistry models propose and refine lead compounds against ADMET constraints.

Robotic Validation

Automated synthesis robots produce leads for high-throughput screening validation.

Clinical Translation

Validated leads enter IND-enabling studies with AI-optimized dosing and patient stratification.

Building the infrastructure of tomorrow's medicine.

Whether you are a researcher, clinician, or partner, let's accelerate the path to better health outcomes together.

Drug discovery,reimagined by AI.